Two contracts in a week for IDOX
Software and services provider IDOX has announced the second contract win of the week for its McLaren Software unit.
Software and services provider IDOX has announced the second contract win of the week for its McLaren Software unit.
McLaren Software has entered an agreement to supply the McLaren Enterprise application software suite and related services to US firm CH2M Hill in a deal worth $405,000 in the first year.
CH2M Hill is a major player in the consulting, design, design-build, operations and programme management arena, with headquarters in Englewood, Colorado. The firm has 30,000 employees in regional offices worldwide with gross revenues of $6.3bn in 2010.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Document management specialist IDOX said McLaren's Enterprise suite will initially be deployed within the Energy & Chemical Division of the US firm to support the vendor document management requirements of one of CH2M's clients.
Earlier in the week, OXY, a subsidiary of US oil and gas giant Occidental Petroleum , signed up to use the McLaren Software enterprise application suite in a deal worth $2.0m in the first year of operation.
JH
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge